Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.48 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.48 |
| ▸ | PLA2G2D | Q9UNK4 | 1/20 | 0.45 |
| ▸ | TRPM8 | Q7Z2W7 | 9/20 | 0.43 |
| ▸ | CETP | P11597 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 3/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16163412 | 0.98 | LPAR3 (0.45) | LPAR3LPAR2PLA2G2DTRPM8CETP | |
| SCHEMBL16163356 | 0.93 | GABBR2 (0.47) | LPAR3LPAR2PLA2G2DTRPM8FDPS | |
| SCHEMBL16163315 | 0.88 | LPAR3 (0.47) | LPAR3LPAR2PLA2G2DTRPM8CETP | |
| SCHEMBL16163279 | 0.86 | LPAR3 (0.44) | LPAR3LPAR2PLA2G2DTRPM8FDPS | |
| SCHEMBL16163303 | 0.85 | LPAR3 (0.53) | LPAR3LPAR2PLA2G2DTRPM8FDPS | |
| SCHEMBL16163115 | 0.81 | GCLC (0.36) | LPAR3LPAR2PLA2G2DFDPS | |
| SCHEMBL16163194 | 0.80 | GABBR2 (0.46) | LPAR3LPAR2PLA2G2DFDPS | |
| SCHEMBL339376 | 0.77 | LPAR3 (0.47) | LPAR3LPAR2PLA2G2DTRPM8 | |
| SCHEMBL11434237 | 0.77 | LPAR3 (0.56) | LPAR3LPAR2FDPS | |
| SCHEMBL3797655 | 0.77 | LPAR3 (0.56) | LPAR3LPAR2FDPS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2791152-B1 | MIXTURES OF DIPHOSPHINIC ACIDS AND DIALKYLPHOSPHINIC ACIDS, A PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF | CLARIANT INT LTD (CH) | 2018-11-07 | — | — | EP | claimed |
| EP-2791149-B1 | MIXTURES OF DIPHOSPHINIC ACIDS AND ALKYLPHOSPHINIC ACIDS, A PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF | CLARIANT INT LTD (CH) | 2017-06-14 | — | — | EP | claimed |
| US-20150005421-A1 | Mixtures Of Diphosphinic Acids And Dialkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2015-01-01 | — | — | US | claimed |
| US-20140329933-A1 | Mixtures Of Diphosphinic Acids And Alkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT INTERNATIONAL LTD. (CH) | 2014-11-06 | — | — | US | claimed |
| US-20140309339-A1 | Mixtures Of Diphosphinic Acids And Alkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2014-10-16 | — | — | US | claimed |
| US-20180030355-A1 | Mixtures Of Diphosphinic Acids And Alkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT INTERNATIONAL LTD. (CH) | 2018-02-01 | — | — | US | disclosed |
| US-20170313942-A1 | Mixtures Of Diphosphinic Acids And Dialkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT INTERNATIONAL LTD. (CH) | 2017-11-02 | — | — | US | disclosed |
| EP-2791149-B1 | MIXTURES OF DIPHOSPHINIC ACIDS AND ALKYLPHOSPHINIC ACIDS, A PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF | CLARIANT INT LTD (CH) | 2017-06-14 | — | — | EP | disclosed |
| US-20150005421-A1 | Mixtures Of Diphosphinic Acids And Dialkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2015-01-01 | — | — | US | disclosed |
| US-20140329933-A1 | Mixtures Of Diphosphinic Acids And Alkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT INTERNATIONAL LTD. (CH) | 2014-11-06 | — | — | US | disclosed |
| US-20140309339-A1 | Mixtures Of Diphosphinic Acids And Alkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | CLARIANT FINANCE (BVI) LIMITED (VG) | 2014-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180030355-A1 | Mixtures Of Diphosphinic Acids And Alkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | PHOSPHO1, ENPP2, INPPL1 | LPAR3 32/4885LPAR2 25/4885PLA2G2D 82/4885 |
| US-20170313942-A1 | Mixtures Of Diphosphinic Acids And Dialkylphosphinic Acids, A Process For The Preparation Thereof And The Use Thereof | C3AR1, DCPS, ENPP2 | LPAR3 48/4885LPAR2 33/4885PLA2G2D 255/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.